Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

LaRussa Michele — Kala Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / LaRussa Michele

LaRussa Michele

Sr. VP, Regulatory and Quality at Kala Pharmaceuticals, Inc. · on record since Jul 19, 2017

Insider trading activity of LaRussa Michele

Transactions on record: 1; since Feb 9, 2018

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 9, 2018

Figures computed from official regulatory filings — methodology.

Companies where LaRussa Michele has traded

Kala Pharmaceuticals, Inc.1 tx · Feb 9, 2018

Track record of LaRussa Michele

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of LaRussa Michele

Co-insiders of LaRussa Michele

Baker Bros. Advisors (GP) LLCKala Pharmaceuticals, Inc.
BAKER BROS. ADVISORS LPKala Pharmaceuticals, Inc.
BAKER FELIXKala Pharmaceuticals, Inc.
BAKER JULIANKala Pharmaceuticals, Inc.
Bazemore ToddKala Pharmaceuticals, Inc.
Berger Chaim D.Kala Pharmaceuticals, Inc.
Blumenkranz Mark S.Kala Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Brazzell Romulus KKala Pharmaceuticals, Inc.

CAXTON CORPKala Pharmaceuticals, Inc.

CDK ASSOCIATES, L.L.C.Kala Pharmaceuticals, Inc.

Chen HongmingKala Pharmaceuticals, Inc.

Colman Yonatan C.Kala Pharmaceuticals, Inc.

CVF, LLCKala Pharmaceuticals, Inc.

ENRIGHT PATRICK GKala Pharmaceuticals, Inc.

Farid MarjanKala Pharmaceuticals, Inc.

Grunberg GregoryKala Pharmaceuticals, Inc.

Hadley Harbor Master Investors (Cayman) L.P.Kala Pharmaceuticals, Inc.

Hanes JustinKala Pharmaceuticals, Inc.

Hill PaulinaKala Pharmaceuticals, Inc.

ISALY SAMUEL DKala Pharmaceuticals, Inc.

Iwicki Mark TKala Pharmaceuticals, Inc.

Kharabi DariusKala Pharmaceuticals, Inc.

Kolchinsky PeterKala Pharmaceuticals, Inc.

KOVEN ANDREW IKala Pharmaceuticals, Inc.

Kovner BruceKala Pharmaceuticals, Inc.

LANGER ROBERTKala Pharmaceuticals, Inc.

Lazar David E.Kala Pharmaceuticals, Inc.

Longitude Capital Partners II, LLCKala Pharmaceuticals, Inc.

Longitude Venture Partners II, L.P.Kala Pharmaceuticals, Inc.

Lux Capital Management, LLCKala Pharmaceuticals, Inc.

Lux Venture Associates II, LLCKala Pharmaceuticals, Inc.

Lux Venture Partners II, L.P.Kala Pharmaceuticals, Inc.

Lux Ventures II, L.P.Kala Pharmaceuticals, Inc.

Lux Ventures II Sidecar LPKala Pharmaceuticals, Inc.

McDermott Charles DouglasKala Pharmaceuticals, Inc.

Minkowitz AvrahamKala Pharmaceuticals, Inc.

Myers C. DanielKala Pharmaceuticals, Inc.

ORBIMED ADVISORS LLCKala Pharmaceuticals, Inc.

OrbiMed Capital GP VI LLCKala Pharmaceuticals, Inc.

OXFORD FINANCE LLCKala Pharmaceuticals, Inc.

Paull Robert BradleyKala Pharmaceuticals, Inc.

PERRY GREGORY DKala Pharmaceuticals, Inc.

Polaris Venture Management Co. V, L.L.C.Kala Pharmaceuticals, Inc.

Polaris Venture Partners Entrepreneurs' Fund V, L.P.Kala Pharmaceuticals, Inc.

Polaris Venture Partners Founders' Fund V, L.P.Kala Pharmaceuticals, Inc.

Polaris Venture Partners Special Founders' Fund V, L.P.Kala Pharmaceuticals, Inc.

Polaris Venture Partners V, L.P.Kala Pharmaceuticals, Inc.

Posen Hillel D.Kala Pharmaceuticals, Inc.

Purdy Brendan P.Kala Pharmaceuticals, Inc.

RA Capital Biotech Fund LPKala Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Kala Pharmaceuticals, Inc.	Feb 9, 2018	AwardD	8,000	0.00 USD	$0	SEC